Australian Medical Equipment Stock News

Earlier this week, CellCarta announced it had entered a partnership with Sonic Healthcare USA, naming Sonic as the first commercial laboratory partner in its Lab Network to support commercialization of companion diagnostics across oncology, autoimmune disease and other precision medicine areas. This collaboration links CellCarta’s assay development capabilities with Sonic’s broad clinical lab footprint, potentially deepening Sonic’s role in higher-value precision testing and companion...

Endeavour Group (ASX:EDV) is restructuring its Pinnacle Drinks business, including a review of its winery footprint and operations. The group plans to sell the Oakridge wine brand and exit or sell other non core winery assets. Winery operations are being consolidated to focus on a tighter set of beverage assets within the Pinnacle portfolio. For investors watching Endeavour Group, this reset follows a period of share price weakness. The stock closed at A$2.86, with the share price down 7.4%...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Even if it's not a huge purchase, we think it was good to see that John Chan, the Non-Executive Chair of Finbar Group...

As Australian shares face a slight retreat, influenced by Wall Street's recent cooling and local inflation concerns, investors are keenly watching how these factors might impact dividend stocks on the ASX. In this environment, identifying robust dividend stocks like Australian Ethical Investment can provide stability and potential income for portfolios amidst market fluctuations.

As Australian shares face a potential retreat, reflecting Wall Street's recent cooling, investors are keenly observing the interplay between local economic indicators and global market trends. In this fluctuating environment, growth companies with substantial insider ownership can be particularly appealing as they often signal confidence from those who know the business best.

Australian shares are set for a slight retreat, influenced by market dynamics both locally and internationally, with Wall Street's recent cooling after hitting new highs. In the context of these fluctuating markets, penny stocks—though an older term—remain relevant as they often represent smaller or newer companies with potential for growth at accessible price points. By focusing on those with strong financial health and solid fundamentals, investors can uncover promising opportunities within...

Goodman Group (ASX:GMG) has been appointed lead development partner for a proposed data centre campus in Sagamihara City, Kanagawa Prefecture, Japan, highlighting its growing role in digital infrastructure and sustainability focused projects. See our latest analysis for Goodman Group. The Sagamihara announcement comes as Goodman Group trades at A$30.77, with a 30 day share price return of 6.47% and a 90 day share price return of 6.32%. The 3 year total shareholder return of 60.30% contrasts...

Nufarm (ASX:NUF) opened H1 2026 with revenue of A$1.7 billion and basic EPS of A$0.07, alongside net income of A$28.0 million. Over the recent half yearly periods, the company has seen revenue move from A$1.8 billion and EPS of A$0.05 in H1 2025 to A$1.6 billion with EPS declining to A$0.54 in H2 2025, before landing at the latest H1 2026 levels. This gives investors a clearer read on how margins are tracking quarter to quarter. Against a backdrop of trailing twelve month losses and analyst...

Fresh from its H1 2026 update, Select Harvests (ASX:SHV) is under the spotlight as you weigh recent revenue and EPS trends against the stock’s A$3.90 share price and what they might signal for profitability. The company has seen half year revenue shift from A$226.4 million in H2 2024 to A$293.8 million in H2 2025, while basic EPS over the same periods moved from A$0.03 to A$0.02, setting up a mixed read on earnings momentum. With trailing 12 month net profit margin at 8.4% versus 8.7% in the...

archTIS Limited ( ASX:AR9 ), might not be a large cap stock, but it led the ASX gainers with a relatively large price...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Insiders who bought Recce Pharmaceuticals Ltd ( ASX:RCE ) stock in the last 12 months were richly rewarded last week...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Australian shares are poised for a slight retreat, influenced by Wall Street's recent cooling and ongoing global economic discussions. Despite the fluctuating market conditions, penny stocks—often overlooked due to their smaller size or newer status—can still present valuable opportunities when backed by solid financials. In this article, we explore several promising Australian penny stocks that combine financial strength with potential for long-term growth.

The Hydration Pharmaceuticals Company Limited's (ASX:HPC) stock rose 33% last week, but insiders who sold US$205m worth...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Retail Food Group Limited's (ASX:RFG) value has fallen 10% in the last week, but insiders who sold AU$523k worth of...

Breville Group Limited ( ASX:BRG ), might not be a large cap stock, but it saw a decent share price growth of 16% on...

Investors who take an interest in Spacetalk Limited ( ASX:SPA ) should definitely note that the Independent...

As the Australian market holds steady, awaiting key inflation data amid global volatility in oil prices and mixed signals from international markets, investors are keenly observing sectors that promise growth potential. In this context, companies with high insider ownership can offer unique insights into future performance, as insiders who have significant stakes often align their interests closely with those of other shareholders.

As the Australian market holds steady, awaiting key economic data like the anticipated April inflation print, investors are keenly observing how these developments might impact stock valuations. In this environment, identifying stocks trading below their intrinsic value can present opportunities for those looking to capitalize on potential market inefficiencies.

As the Australian market holds steady, awaiting key inflation data, the broader sentiment remains cautious amid global economic shifts and volatile commodity prices. In this environment, identifying promising small-cap stocks requires a keen eye for potential growth drivers and resilience in challenging conditions.

As the Australian market holds steady, waiting for crucial inflation data, investors are keeping a close eye on potential opportunities amidst global economic shifts. Penny stocks, a term that may seem outdated but remains relevant, represent smaller or newer companies with potential for growth and value. By focusing on those with strong financials and clear growth trajectories, investors can uncover promising opportunities in this unique segment of the market.